Studies of fibrinogen binding to porcine platelets by flow cytometry: A method for studies of porcine platelet activation

Platelets

Volumn 13, Issue 3, 2002, Pages 153-157

  Larsson, Anders ^a   Eriksson, Mats ^a   Lindahl, Tomas L ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; FIBRINOGEN; FIBRINOGEN ANTIBODY; FIBRINOGEN RECEPTOR; PROTEIN ANTIBODY; RISTOCETIN; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; SWINE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PLATELETS; FIBRINOGEN; FLOW CYTOMETRY; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET FUNCTION TESTS; PROTEIN BINDING; RISTOCETIN; SWINE; THROMBIN;

GALLUS GALLUS; SUIDAE; SUS SCROFA;

EID: 0036284479     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953371027588     Document Type: Article

References (24)

1. Thromboregulation by endothelial cells: Significance for occlusive vascular diseases
2. Pathophysiology of coronary thrombosis
3. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease
4. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I. Pathophysiological and pharmacological features
5. Antithrombotic therapy in acute coronary syndromes
6. Integrin structure
7. Signaling through platelet integrin alpha IIb beta 3: Inside-out, outside-in, and sideways
8. Platelet glycoprotein IIb/IIIa receptor antagonists and coronary artery disease
9. Antiplatelet agents in stroke prevention, combination therapy: Present and future
10. Studies of fibrinogen binding to platelets by flow cytometry: An improved method for detection of platelet activation
11. How the protease thrombin talks to cells
12. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not
13. Retinyl palmitate injections reduce serum levels and effects of endotoxin on systemic haemodynamics and oxygen transport in the pig
14. Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders
15. Adenosine diphosphate as a mediator of platelet aggregation in vivo
16. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: Comparison with other aggregation methodologies
17. Bleeding time and concentrations of von Willebrand factor in patients with acute upper gastrointestinal bleeding
18. Thrombocytopenia and platelet microvesicle formation caused by Legionella pneumophila infection
19. Endotoxin induced platelet microvesicle formation measured by flow cytometry
20. Impaired platelet function in endotoxemic pigs analyzed by flow cytometry
21. Chicken IgG: Utilizing the evolutionary advantage
22. Clq binding to platelets induced by monoclonal antibodies and immune complexes: A flow cytometric analysis
23. Platelet activation and binding of complement components to platelets induced by immune complexes
24. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood